Clinical Trials List
Protocol NumberFB-1603_TACE_PII_2022_1
Active
2023-05-01 - 2028-12-31
Phase I/II
Recruiting2
ICD-10K70.0
Alcoholic fatty liver
ICD-9571.0
Alcoholic fatty liver
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳志宏 Division of Radiology
- - - Division of Radiology
- 張智凱 Division of Radiology
- Shih-Jer Hsu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 滕威 Digestive System Department
- 李兆偉 Division of General Surgery
- 林伯庭 Digestive System Department
- 鄭志軒 Division of Gastroenterological Surgery
- 吳宗翰 Division of Gastroenterological Surgery
- Wei-Chen Lee Division of Gastroenterological Surgery
- 洪豪謙 Division of Gastroenterological Surgery
- Chung-Wei Su Digestive System Department
- 吳庭榕 Division of Gastroenterological Surgery
- 周宏學 Division of Gastroenterological Surgery
- Kun-Ming Chan Division of Gastroenterological Surgery
- 王瑜肇 Division of Gastroenterological Surgery
- 李勁樵 Division of Gastroenterological Surgery
- Yi-Chung Hsieh Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
120 participants
